Erwin Troxler
Direttore Finanziario/CFO presso HBM HEALTHCARE INVESTMENTS AG
Patrimonio netto: 953 391 $ in data 30/04/2024
Profilo
Erwin Troxler currently works at Schweizer Verband der Investmentgesellschaften, as Chairman from 2014, HBM Partners AG, as Chief Financial Officer from 2005, and HBM Healthcare Investments AG, as Chief Financial Officer from 2011.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2023 | 4 691 ( 0.07% ) | 953 391 $ | 30/04/2024 |
Posizioni attive di Erwin Troxler
| Società | Posizione | Inizio |
|---|---|---|
| HBM HEALTHCARE INVESTMENTS AG | Direttore Finanziario/CFO | 01/11/2011 |
| Schweizer Verband der Investmentgesellschaften | Presidente | 01/01/2014 |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Direttore Finanziario/CFO | 01/01/2005 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
HBM Healthcare Investments AG
 HBM Healthcare Investments AG Investment ManagersFinance HBM Healthcare Investments AG is a listed investment company which invests worldwide, primarily focusing on Europe, Asia and North America, in private and public companies in the human medicine, biotechnology, medical technology and diagnostics sectors, and related areas. It aims to invest mainly in a form of equity, but also considers convertible bonds, debt securities and derivatives. The investment focus is on later stage companies, and participates in follow-on investment rounds, also acquiring majority stake in target companies. It invests also in other funds. | Finance |
| Schweizer Verband der Investmentgesellschaften | |
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Finance |
- Borsa valori
- Insiders
- Erwin Troxler
